secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARDINAL HEALTH INC (CAH)
CIK:        0000721371
Form:       8-K
Filed at:   2023-06-08T23:59:59+00:00
Accession:  0000721371-23-000035
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardinal Health raises FY2023 EPS outlook, provides FY2024 guide of $6.45-$6.70, $3.5B buyback
--------------------------------------------------------------------------------

- Narrows FY2023 non-GAAP EPS guidance to $5.65-$5.80 (mid-point 13% growth); preliminary FY2024 guidance $6.45-$6.70 (15% growth).
- Long-term target: 12%-14% non-GAAP EPS CAGR over FY2024-2026; Pharmaceutical segment profit growth 4%-6%.
- Board approves new $3.5B share repurchase authorization through 2027; plans at least $2B in buybacks over next three years.
- Launches Navista Network for community oncology; retains and invests in Nuclear & Precision Health Solutions.
- Medical Improvement Plan targets $650M+ segment profit by FY2026; $400M expected in FY2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/721371/000072137123000035/0000721371-23-000035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/721371/000072137123000035/cah-20230608.htm
  HTML page:      https://secwatch.observer/filing/0000721371-23-000035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer